Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
Year: 2017
Type: article
Study design: Case Report
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2746940679
